TR201819312A2 - Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu - Google Patents
Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu Download PDFInfo
- Publication number
- TR201819312A2 TR201819312A2 TR2018/19312A TR201819312A TR201819312A2 TR 201819312 A2 TR201819312 A2 TR 201819312A2 TR 2018/19312 A TR2018/19312 A TR 2018/19312A TR 201819312 A TR201819312 A TR 201819312A TR 201819312 A2 TR201819312 A2 TR 201819312A2
- Authority
- TR
- Turkey
- Prior art keywords
- fesoterodine
- tablet formulation
- bilayer tablet
- bilayer
- pharmaceutically acceptable
- Prior art date
Links
- DCCSDBARQIPTGU-HSZRJFAPSA-N fesoterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(CO)C=2)OC(=O)C(C)C)=CC=CC=C1 DCCSDBARQIPTGU-HSZRJFAPSA-N 0.000 title abstract 2
- 229960002978 fesoterodine Drugs 0.000 title abstract 2
- 239000007916 tablet composition Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut buluş; fesoterodin veya fesoterodinin farmasötik olarak kabul 5 edilebilir bir tuzunu içeren bir çift katmanlı tablet formülasyonu ile ilgilidir.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/TR2018/050859 WO2019221684A2 (en) | 2017-12-25 | 2018-12-21 | The bilayer tablet formulation of fesoterodine |
EP18915776.1A EP3731826A2 (en) | 2017-12-25 | 2018-12-21 | The bilayer tablet formulation of fesoterodine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/21437A TR201721437A2 (tr) | 2017-12-25 | 2017-12-25 | Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201819312A2 true TR201819312A2 (tr) | 2019-07-22 |
Family
ID=67900979
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/21437A TR201721437A2 (tr) | 2017-12-25 | 2017-12-25 | Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari |
TR2018/19312A TR201819312A2 (tr) | 2017-12-25 | 2018-12-13 | Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu |
TR2018/19274A TR201819274A2 (tr) | 2017-12-25 | 2018-12-13 | Fesoterodi̇ni̇n uzatilmiş salim sağlayan kompozi̇syonlari |
TR2018/19578A TR201819578A2 (tr) | 2017-12-25 | 2018-12-17 | Fesoterodi̇n fumaratin tablet kompozi̇syonlari |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/21437A TR201721437A2 (tr) | 2017-12-25 | 2017-12-25 | Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2018/19274A TR201819274A2 (tr) | 2017-12-25 | 2018-12-13 | Fesoterodi̇ni̇n uzatilmiş salim sağlayan kompozi̇syonlari |
TR2018/19578A TR201819578A2 (tr) | 2017-12-25 | 2018-12-17 | Fesoterodi̇n fumaratin tablet kompozi̇syonlari |
Country Status (3)
Country | Link |
---|---|
EP (4) | EP3731829B1 (tr) |
TR (4) | TR201721437A2 (tr) |
WO (3) | WO2019194772A2 (tr) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0957073A1 (en) | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
DE19955190A1 (de) | 1999-11-16 | 2001-06-21 | Sanol Arznei Schwarz Gmbh | Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen |
ES2370943T3 (es) * | 2006-06-09 | 2011-12-23 | Ucb Pharma Gmbh | Composiciones farmacéuticas estabilizadas que comprenden fesoterodina. |
US7807715B2 (en) | 2006-06-09 | 2010-10-05 | Ucb Pharma Gmbh | Pharmaceutical compositions comprising fesoterodine |
WO2010043408A2 (de) | 2008-10-17 | 2010-04-22 | Ratiopharm Gmbh | Mikroverkapseltes fesoterodin |
EP2508173A1 (en) * | 2011-04-08 | 2012-10-10 | LEK Pharmaceuticals d.d. | Stabilized pharmaceutical composition comprising fesoterodine |
US20130236544A1 (en) | 2012-03-08 | 2013-09-12 | Dr. Reddy's Laboratories Ltd. | Stable pharmaceutical compositions of fesoterodine |
US20150182629A1 (en) * | 2012-07-02 | 2015-07-02 | Hetero Research Foundation | Stable compositions of fesoterodine |
BR112015021630A2 (pt) * | 2013-03-07 | 2017-07-18 | Amneal Pharmaceuticals Llc | estabilização de fármacos sensíveis à umidade |
WO2015022703A1 (en) * | 2013-08-12 | 2015-02-19 | Genepharm India Private Limited | A stable pharmaceutical composition of fesoterodine hydrochloride |
HUE049598T2 (hu) * | 2014-01-21 | 2020-09-28 | Bpsi Holdings Llc | Közepes láncú glicerideket tartalmazó, közvetlen kibocsátású film bevonatok, és az ezekkel bevont hordozók |
-
2017
- 2017-12-25 TR TR2017/21437A patent/TR201721437A2/tr unknown
-
2018
- 2018-12-13 TR TR2018/19312A patent/TR201819312A2/tr unknown
- 2018-12-13 TR TR2018/19274A patent/TR201819274A2/tr unknown
- 2018-12-17 TR TR2018/19578A patent/TR201819578A2/tr unknown
- 2018-12-21 WO PCT/TR2018/050855 patent/WO2019194772A2/en unknown
- 2018-12-21 EP EP18849451.2A patent/EP3731829B1/en active Active
- 2018-12-21 WO PCT/TR2018/050858 patent/WO2019209220A2/en unknown
- 2018-12-21 EP EP18913635.1A patent/EP3731931A4/en active Pending
- 2018-12-21 WO PCT/TR2018/050859 patent/WO2019221684A2/en unknown
- 2018-12-21 EP EP18915776.1A patent/EP3731826A2/en active Pending
- 2018-12-21 EP EP18911327.7A patent/EP3731825A2/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3731931A4 (en) | 2021-11-03 |
TR201819578A2 (tr) | 2019-07-22 |
WO2019194772A2 (en) | 2019-10-10 |
EP3731826A2 (en) | 2020-11-04 |
EP3731829A1 (en) | 2020-11-04 |
WO2019209220A2 (en) | 2019-10-31 |
WO2019221684A2 (en) | 2019-11-21 |
EP3731829B1 (en) | 2024-07-17 |
EP3731825A2 (en) | 2020-11-04 |
TR201819274A2 (tr) | 2019-07-22 |
WO2019221684A3 (en) | 2020-01-30 |
TR201721437A2 (tr) | 2019-07-22 |
EP3731931A2 (en) | 2020-11-04 |
WO2019194772A3 (en) | 2020-01-02 |
WO2019209220A3 (en) | 2019-12-26 |
WO2019194772A9 (en) | 2020-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201807942D0 (en) | Pharmaceutical formulation | |
PH12017502431A1 (en) | Pharmaceutical formulations comprising tenofovir and emtrictabine | |
IL271226A (en) | medical preparation | |
MX2017016802A (es) | Formulaciones farmaceuticas. | |
EP3603642A4 (en) | PHARMACEUTICAL PREPARATION | |
IL273704A (en) | Pharmaceutical bilayer tablet formulations | |
SG11202010124SA (en) | Stable pharmaceutical formulation | |
ZA202102871B (en) | Pharmaceutical formulation | |
IL278927A (en) | pharmaceutical preparation | |
IL290894A (en) | pharmaceutical preparation | |
MX2018005358A (es) | Comprimido de dosis alta que contiene mesalazina optimizado. | |
EP3646866A4 (en) | PHARMACEUTICAL PREPARATION | |
IL282343A (en) | soluble medicinal compounds | |
HUE064474T2 (hu) | Gyógyászati kiszerelés | |
IL271673A (en) | Preparations containing drugs with increased solubility | |
WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
ZA202006346B (en) | Pharmaceutical preparation | |
TR201819312A2 (tr) | Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu | |
MX2016006742A (es) | Composicion farmaceutica. | |
IL271908A (en) | Over-compressed pharmaceutical preparations | |
EA201691422A1 (ru) | Перорально распадающиеся таблетированные составы мемантина | |
EP3697393A4 (en) | PHARMACEUTICAL DOSAGE FORMS | |
GB201906473D0 (en) | Pharmaceutical formulation | |
PL3720424T3 (pl) | Preparat farmaceutyczny | |
WO2019059868A3 (en) | PHARMACEUTICAL COMBINATIONS OF TENOFOVIR, EMTRICITABINE AND EFAVIRENZ |